IntraBio Reports Further Detail On Positive Data From IB1001 Multinational Clinical Trial For The Treatment of GM2 Gangliosidosis
First positive clinical trial for GM2 Gangliosidosis – IB1001 demonstrated statistically significant and clinically meaningful…